Linsitinib
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for Linsitinib, covering 2015-03-13 to 2026-08-26. Get the full timeline:
Most recent: Clinical Trial Results: A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED) [Phase 2, Phase 3]